Skip to main content

Table 1 Clinical data of patients with MAPT R406W mutation in a novel Swedish family

From: Slowly progressive dementia caused by MAPT R406W mutations: longitudinal report on a new kindred and systematic review

Identifier

R406W

Sex

AoO, years

DD

Clinical diagnosis

APOE

Early or presenting symptoms

Visuospatial

Type of memory impairment

Language impairment

Other cognitive or behavioral symptoms

LoI, psychiatric symptoms

Parkinsonism, other neurological findings

II-1

(Mut)

F

70

9D

Dementia NOS

N/A

N/A

N/A

N/A

N/A

Aggression and wandering behavior

N/A

N/A

III-1

N/A

F

57

2(d)

None

N/A

N/A

N/A

N/A

N/A

Social withdrawala

N/A

None

III-3

Mut

F

53

27D

AD

ε3/ε3

Prosopagnosiaa

N/A

Episodic

Reduced output, echolalia (26)

Shallow emotions (7), slight disinhibition, confabulation

LoI (8), anxiety, paranoid tendencies

Rigidity and bradykinesia (25), unexplained falls, dyskinesias in lower jaw

III-4

N/A

M

58

17D

AD

ε4/ε4

Memory impairment

Impaired

Episodic and semantic

Apraxia of speech

Disinhibition, aggression and sexual suggestions (9), DV, wandering behavior, confabulation

Severe LoI

None

III-5

(Mut)

M

63

14D

N/A

N/A

N/A

N/A

N/A

N/A

Dyscalculia, dysfunctional at household chores, mild behavioral symptoms (11) wandering behavior (11–14)

Severe LoI, anxiety (14)

None

III-6

Mut

F

50

26D

AD

ε3/ε3

Dyscalculia, social withdrawal, lack of initiative

Mild Q, impaired (24)

Learning difficulties

Reduced spontaneous output

Emotional lability, DV (1), mood changes, perseverations, and confabulation (6), disinhibition, aggression and rude language (18), wandering behavior (24)

LoI, anxiety

Bradykinesia, mild rigidity and dysdiadochokinesia (24), slight tremora, dyspraxia of left hand, dysphagiaa

IV-9

Mut

M

51

12(a)

MCI

N/A

Irritabilitya, visuospatial difficultiesa, short-term memory loss

N/A

Short-term memory loss

Dyslexia and dysnomia (5)

Confabulation (5), irritability

Mild LoI, anxiety, emotional lability (5)

None

IV-16

Mut

F

52

6(a)

None

N/A

Anxiety, memory impairment

Q (3)

Episodic (3)

No

Disinhibition

Mild LoI

None

  1. Mut R406W heterozygote, (Mut) Obligate carrier of R406W, AoO Age of (symptom) onset, DD disease duration, D indicates disease duration until death, (d) indicates death of an unrelated cause (cancer), and (a) alive, APOE Apolipoprotein E genotype, NOS Not otherwise specified, AD Alzheimer disease, MCI Mild cognitive impairment, N/A Not available, LoI Loss of insight, DV Déjà vu-like experiences (i.e. spontaneously recognizing an unknown place or person), Q qualitative impairment
  2. Numbers in parentheses indicate disease duration at which particular symptom was reported
  3. aSelf-reported or reported by relatives